focus -WSS

focus

author：fashion 2025-10-02 23:47:42 - browse：867

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Many immigrants are left out of maternal health programs

WSS

Listen: Vivek Ramaswamy's star turn & leaky drug data

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

National associations that represent hospice owe an apology

Wegovy improves function in certain heart failure patients

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Wikipedia

focus

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Many immigrants are left out of maternal health programs

BioMarin wins approval for gene therapy to treat hemophilia A

What AstraZeneca

New air purifier tech could be key to improving indoor air quality

Poland's lawmakers approve a divisive law on Russian influence

United colonoscopy coverage change 'may cost lives,' doctors say

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Trump demands the U.S. pay no more for drugs than other countries … again

How the first Native Hawaiian psychiatrist helped diversify medicine

focus

As obesity drug market grows, telehealth companies court payers

PBMs are inflating the cost of generic drugs. They must be reined in

Health officials lay out plans to cope with respiratory virus season

How to make over

Roche's accidental data boosts hopes for anti

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

hotspot

hotspot

focus

knowledge